Científicos de Cambridge afirman que ayudaría a proteger contra una variedad de virus y prevenir futuras pandemias

Cambridge scientists look for what is 'essential for viral life' to future-proof vaccines

Researchers have developed a new way to prevent people falling ill with potential pandemic level viruses - before they have even become a threat.

Sono già buoni i risultati della sperimentazione di fase 1: a realizzarlo l'Università di Cambridge

A new AI-designed vaccine capable of protecting against entire families of viruses could transform how the world prepares for a future pandemic.

Un nuovo vaccino progettato con l’intelligenza artificiale, in grado di proteggere intere famiglie di virus, potrebbe cambiare il modo in cui il mondo si prepara a una futura…

AI-designed ‘super-antigen’ vaccine passes first human trial, raising hopes for future-proof protection against coronavirus families and emerging pandemics.

La IA ha sido capaz de analizar los códigos genéticos de distintas variantes de coronavirus para diseñar un 'superantígeno'.

Lo studio dell'Università di Cambridge punta a sviluppare vaccini universali contro coronavirus, influenza ed Ebola, con l'obiettivo di prevenire future pandem…

Vaccino universale progettato con IA supera primi test clinici: protegge da Covid, Ebola e virus futuri. Scopri come Cambridge anticipa le pandemie con l'intelligenza artificiale.

Cambridge scientists have successfully completed the first human trial of an AI-designed universal coronavirus vaccine, aiming to protect against future pa

The experimental jab is intended to target a wide range of viruses, including those behind deadly outbreaks like Sars, Mers and Covid-19.

Científicos de Cambridge afirman que ayudaría a proteger contra una variedad de virus y prevenir futuras pandemias

Cientistas de Cambridge dizem ter testado pela primeira vez em pessoas uma vacina projetada por IA

University of Cambridge completes first human trial of an AI-designed vaccine targeting all coronaviruses, showing safety and immune responses in 39

Investigadores de Cambridge y DIOSynVax probaron la vacuna en 39 voluntarios sanos en el Reino Unido

University of Cambridge completes first human trial of an AI-designed vaccine, showing safety and broad immune response against multiple coronaviruses in 39

Cambridge researchers used AI to design a 'universal vaccine' that may protect against thousands of viruses and future mutations; first human trial found it safe and able to…